830 related articles for article (PubMed ID: 11593335)
41. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
[TBL] [Abstract][Full Text] [Related]
43. Perspectives for the gene therapy of malignant gliomas by suicide gene transfer.
Di Meco F; Benedetti S; Colombo MP; Finocchiaro G
J Neurosurg Sci; 1997 Sep; 41(3):227-34. PubMed ID: 9444575
[TBL] [Abstract][Full Text] [Related]
44. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Wildner O; Blaese RM; Candotti F
Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
[TBL] [Abstract][Full Text] [Related]
45. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
Touraine RL; Vahanian N; Ramsey WJ; Blaese RM
Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537
[TBL] [Abstract][Full Text] [Related]
47. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
48. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
49. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
50. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
Haberkorn U; Khazaie K; Morr I; Altmann A; Müller M; van Kaick G
Nucl Med Biol; 1998 May; 25(4):367-73. PubMed ID: 9639298
[TBL] [Abstract][Full Text] [Related]
51. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
[TBL] [Abstract][Full Text] [Related]
52. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
53. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
Wildner O; Blaese RM; Morris JC
Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
[TBL] [Abstract][Full Text] [Related]
54. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.
Huang Q; Pu P; Xia Z; You Y
J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907
[TBL] [Abstract][Full Text] [Related]
55. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
56. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
57. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
58. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
59. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
60. Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.
Robe PA; Nguyen-Khac MT; Lambert F; Lechanteur C; Jolois O; Ernst-Gengoux P; Rogister B; Bours V
Int J Oncol; 2007 Jan; 30(1):283-90. PubMed ID: 17143539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
